Anti-CLL1 Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed/Refractory Acute Myeloid Leukemia

Hui Zhang(Shanghai Jiao Tong University), Hua Jiang(Shanghai East Hospital)
Clinical Cancer Research
April 8, 2021
Cited by 101


Related Papers